Of note, primary (Figure 1A,B) and secondary (metastases) brain tumors (Figure 3B,C) display relatively high expression of CD73 compared to other types of tumors, which may prioritize CD73-based targeted therapy for either primary or secondary brain tumors. The gene discussed is NT5E; the disease is brain neoplasm.